Bladder Cancer - Results from #180

Bladder cancer mortality after a diagnosis of nonmuscle-invasive bladder carcinoma. July 4, 2019

Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification. July 4, 2019

Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer. July 3, 2019

COMPLIANCE WITH AMERICAN UROLOGICAL ASSOCIATION GUIDELINES FOR NON-MUSCLE INVASIVE BLADDER CANCER REMAINS POOR: ASSESSING FACTORS ASSOCIATED WITH NON-COMPLIANCE AND SURVIVAL IN A RURAL STATE. July 3, 2019

A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer. July 3, 2019

New Patient Resource from NCCN Helps People with Bladder Cancer Make Informed Treatment Decisions July 2, 2019

The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: A systematic review. July 2, 2019

Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette-Guérin immunotherapy. July 2, 2019

Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer. July 2, 2019

Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities. July 1, 2019

Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry. July 1, 2019

Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options? July 1, 2019

Urinary metabolomic signature of muscle-invasive bladder cancer: A multiplatform approach. June 28, 2019

Reduction of Pain During Flexible Cystoscopy: A Systematic Review and Meta-Analysis. June 28, 2019

Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma. June 28, 2019

Expression of miR-100 and miR-138 as prognostic biomarkers in Non- Muscle Invasive Bladder Cancer. June 27, 2019

Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer. June 27, 2019

Clinical implications of molecular subtyping in bladder cancer. June 27, 2019

Influence of preoperative hydronephrosis and ureteral orifice involvement in the survival of patients undergoing radical cystectomy: A retrospective comparative study. June 26, 2019

Immunogenomic Analysis of Exceptional Responder to ALT-803 (IL-15 Analogue) in BCG Unresponsive Nonmuscle Invasive Bladder Cancer: A Case Series and Review of the Literature. June 26, 2019

Page 10 of 303

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.